Article Details
Retrieved on: 2021-02-24 12:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Pfizer's Regulatory Application For Tick-borne Encephalitis Vaccine Accepted For Priority Review. Pfizer Inc. (NYSE: PFE) said the FDA has accepted for ...
Article found on: www.benzinga.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here